« Back to Record
Citation APA

Seremet, T. T., Jansen, Y. Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P., & Neyns, B. (2019). Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy. Journal of translational medicine, 17(1), 303. doi:10.1186/s12967-019-2051-8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296798

Seremet, T. T., Jansen, Y. Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P., & Neyns, B. (2019). Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy. Journal of translational medicine, 17(1), 303. doi:10.1186/s12967-019-2051-8